https://www.selleckchem.com/products/vh298.html
ent in treatment outcomes. However, to confirm the efficacy and safety of such use, further careful observation in more cases is required. We were able to administer remdesivir to six Japanese patients with moderate COVID-19 on hemodialysis safely. It is expected that the safe use of remdesivir will bring an increase in treatment options for moderate cases of COVID-19 in dialysis patients as well as subsequent improvement in treatment outcomes. However, to confirm the efficacy and safety of such use, further careful observation in more ca
Curtir
Comentario
Compartilhar
